Treatment of IBS-D with 5-HT3 receptor antagonists vs spasmolytic agents: Similar therapeutical effects from heterogeneous pharmacological targets

Neurogastroenterology and Motility

Volumn 23, Issue 12, 2011, Pages 1051-1055

  Clavé, Pere ^a,b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL DE MATARÓ   (Spain)

^c Fundacio de Gastroenterologia Dr F Vilardell   (Spain)

Author keywords

Antispasmodics; Irritable bowel syndrome and diarrhea; Ramosetron

Indexed keywords

ALOSETRON; CILANSETRON; CIMETROPIUM; MEBEVERINE; OTILONIUM BROMIDE; PAPAVERINE; PEPPERMINT OIL; PINAVERIUM BROMIDE; PIRENZEPINE; PLACEBO; RAMOSETRON; SCOPOLAMINE; SEROTONIN 3 ANTAGONIST; SPASMOLYTIC AGENT;

ABDOMINAL CRAMP; ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ARTICLE; COLON MOTILITY; CONSTIPATION; DEFECATION; DEFECATION URGENCY; DIARRHEA; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TARGETING; DRUG TOLERABILITY; GASTROINTESTINAL MOTILITY; GIANT MIGRATING CONTRACTION; HUMAN; HYPERALGESIA; INTESTINAL DYSMOTILITY; IRRITABLE COLON; ISCHEMIC COLITIS; LONG TERM CARE; MULTICENTER STUDY (TOPIC); NEUROMUSCULAR BLOCKING; NEUROMUSCULAR TRANSMISSION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SENSORY NERVE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE RELAXATION; SYNAPTIC TRANSMISSION;

BENZIMIDAZOLES; DIARRHEA; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; PARASYMPATHOLYTICS; PHENETHYLAMINES; SEROTONIN 5-HT3 RECEPTOR ANTAGONISTS;

EID: 81855194798     PISSN: 13501925     EISSN: 13652982     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2011.01808.x     Document Type: Article

References (25)

1. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-91. Erratum in: Gastroenterology 2006; 131(2): 688.
2. Hungin APS, Whorwell PJ, Tack J, Mearin F. The prevalence, patterns and impact of irritable bowel syndrome: an international survey of 40, subjects. Aliment Pharmacol Ther 2003; 17: 643-50.
3. Guilera M, Balboa A, Mearin F. Bowel habit subtypes and temporal patterns in irritable bowel syndrome: systematic review. Am J Gastroenterol 2005; 100: 1174-84.
4. Lee KJ, Kim NY, Kwon JK et al. Efficacy of ramosetron in the treatment of male patients with irritable bowel syndrome with diarrhea: a multicenter, randomized clinical trial, compared with mebeverine. Neurogastroenterol Motil 2011; 23: 1098-104.
5. Tack J, Fried M, Houghton LA, Spicak J, Fisher G. Systematic review: the efficacy of treatments for irritable bowel syndrome - a European perspective. Aliment Pharmacol Ther 2006; 24: 183-205.
6. Ford AC, Talley NJ, Spiegel BM et al. Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta-analysis. BMJ 2008; 337: a2313.
7. Whitehead WE, Corazziari E, Prizont R, Senior JR, Thompson WG, Veldhuyzen Van Zanten SJ. Definition of a responder in clinical trials for functionalgastrointestinal disorders: report on a symposium. Gut 1999; 45(Suppl 2): II78-9.
8. Kruis W, Weinzierl M, Schüssler P, Holl J. Comparison of the therapeutic effect of wheat bran, mebeverine and placebo in patients with the irritable bowel syndrome. Digestion 1986; 34: 196-201.
9. Tudor GJ. A general practice study to compare alverine citrate with mebeverine hydrochloride in the treatment of irritable bowel syndrome. Br J Clin Pract 1986; 40: 276-8.
10. Chapman ND, Grillage MG, Mazumder R, Atkinson SN. A comparison of mebeverine with high-fibre dietary advice and mebeverine plus ispaghula in the treatment of irritable bowel syndrome: an open, prospectively randomised, parallel group study. Br J Clin Pract 1990; 44: 461-6. PubMed PMID: 2177997.
11. Clavé P, Acalovschi M, Triantafillidis JK et al. Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome. Aliment Pharmacol Ther 2011; 34: 432-42.
12. Ruepert L, Quartero AO, de Wit NJ, van der Heijden GJ, Rubin G, Muris JW. Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2011; 8: CD003460.
13. Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000; 133(2): 136-47.
14. Sainsbury A, Ford AC. Treatment of irritable bowel syndrome: beyond fiber and antispasmodic agents. Therap Adv Gastroenterol 2011; 4: 115-27.
15. Spiller R. Serotoninergic modulating drugs for functional gastrointestinal diseases. Br J Clin Pharmacol 2002; 54: 11-20.
16. Ford AC, Brandt LJ, Young C, Chey WD, Foxx-Orenstein AE, Moayyedi P. Efficacy of 5-HT3 antagonists and 5-HT4 agonists in irritable bowel syndrome: systematic review and meta-analysis. Am J Gastroenterol 2009; 104: 1831-43.
17. Cremonini F, Delgado-Aros S, Camilleri M. Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol Motil 2003; 15: 79-86.
18. Drossman DA, Camilleri M, Mayer EA, Whitehead WE. AGA technical review on irritable bowel syndrome. Gastroenterology 2002; 123: 2108-31.
19. Kanazawa M, Palsson OS, Thiwan SI et al. Contributions of pain sensitivity and colonic motility to IBS symptom severity and predominant bowel habits. Am J Gastroenterol 2008; 103: 2550-61.
20. Spiller R. Role of motility in chronic diarrhoea. Neurogastroenterol Motil 2006; 18: 1045-55.
21. Sarna SK. Colonic Motility: From Bench Side to Bedside. San Rafael, CA: Morgan & Claypool Life Sciences, 2010.
22. Aulí M, Martínez E, Gallego D et al. Effects of excitatory and inhibitory neurotransmission on motor patterns of human sigmoid colon in vitro. Br J Pharmacol 2008; 155: 1043-55.
23. Gallego D, Aulí M, Aleu J et al. Effect of otilonium bromide on contractile patterns in the human sigmoid colon. Neurogastroenterol Motil 2010; 22: e180-91.
24. Galligan JJ. Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil 2002; 14: 611-23.
25. Kadowaki M, Wade PR, Gershon MD. Participation of 5-HT3, 5-HT4, and nicotinic receptors in the peristaltic reflex of guinea pig distal colon. Am J Physiol 1996; 271(5 Pt 1): G849-57.